IEXLENS
Log inSign up
Trending searchesBTCETHSOLXRPDOGE

NVS

Novartis AGNYSE
155.51 USDT+1.08%Bitget perpetual · refreshed every 30s
24h value$346.4KOpen interest$33.0KFunding-0.0734%novartis.com ↗
Post in room

Key filings

All filings on SEC ›

Earnings, material events (8-K), quarterly and annual reports, ownership reports

  • 2026-10-276-KCurrent report (foreign issuer)Source ↗
  • 2026-09-086-KCurrent report (foreign issuer)Source ↗
  • 2026-09-046-KCurrent report (foreign issuer)Source ↗
  • 2026-09-016-KCurrent report (foreign issuer)Source ↗
  • 2026-07-216-KCurrent report (foreign issuer)Source ↗
  • 2026-06-116-KCurrent report (foreign issuer)Source ↗
  • 2026-04-286-KCurrent report (foreign issuer)Source ↗
  • 2026-03-186-KCurrent report (foreign issuer)Source ↗
  • 2026-02-046-KCurrent report (foreign issuer)Source ↗
  • 2026-02-046-KCurrent report (foreign issuer)Source ↗
  • 2026-02-0420-FAnnual report (foreign issuer)Source ↗
  • 2025-11-256-KCurrent report (foreign issuer)Source ↗
  • 2025-11-206-KCurrent report (foreign issuer)Source ↗
  • 2025-11-056-KCurrent report (foreign issuer)Source ↗
  • 2025-10-286-KCurrent report (foreign issuer)Source ↗

Filings are in English. Form and item labels are only a classification to help you navigate and do not interpret the filing.

Insider trades & planned sales

Stock transactions by officers and major holders (Form 4) and notices of proposed sale (Form 144)

✈ Contact on Telegram